换一批
换一批
作者：
关键词
55 serological assays have received EUA. NonethelessCOVID-19SARS-CoV-2The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2019 was met with a rapid introduction of commercially available serological assays for SARS-CoV-2 antibody detection. Soon after being declared an emergency in the USas laboratories gained access to this unprecedented number of assaysexceeding the number of assays available for any other infectious disease and most other laboratory analytes. As a result of this rapid expansion and at times dubious qualityhundreds of serological assays for SARS-CoV-2 were introducedserologythe Food and Drug Administration (FDA) began reviewing and regulating all SARS-CoV-2 serological assays under emergency use authorization (EUA). To datethe utility of SARS-CoV-2 serological testing remained unclear
主题词
抗体, 中和(Antibodies, Neutralizing);抗体, 病毒(Antibodies, Viral);人类(Humans);免疫, 体液(Immunity, Humoral);疾病大流行(Pandemics)
DOI
10.1093/clinchem/hvab039
PMID
33772260
发布时间
2021-05-12
- 浏览1
Clinical chemistry
707-709页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
